Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (231-240 of 331) with videos related to

Pageof 34
Sort By:
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
Circulation|October 26, 2011
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarctionJudith S Hochman, Harmony R Reynolds, Vladimír Dzavík, et al.
American Heart Journal|March 20, 2012
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)Harmony R Reynolds, Sandra A Forman, Jacqueline E Tamis-Holland, et al.
Circulation|March 29, 2014
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice GuidelinesJeffrey L Anderson, Paul A Heidenreich, Paul G Barnett, et al.
Journal of the American College of Cardiology|April 1, 2014
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice GuidelinesJeffrey L Anderson, Paul A Heidenreich, Paul G Barnett, et al.
JAMA|December 7, 2006
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantationEric L Eisenstein, Kevin J Anstrom, David F Kong, et al.
Circulation. Cardiovascular Quality and Outcomes|December 7, 2020
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection FractionDerek S Chew, Zak Loring, Jatin Anand, et al.
JAMA Cardiology|November 5, 2022
Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic DissectionE Hope Weissler, Oyomoare L Osazuwa-Peters, Melissa A Greiner, et al.
Circulation. Arrhythmia and Electrophysiology|April 13, 2021
Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation: Findings From the CABANA Imaging SubstudyMaryam E Rettmann, David R Holmes, Kristi H Monahan, et al.
Pageof 34

Showing results (231-240 of 331) with videos related to

Sort By:
Pageof 34
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Journal of the American College of Cardiology|July 25, 2020
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFTJeanne E Poole, Brian Olshansky, Daniel B Mark, et al.
Circulation|October 26, 2011
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarctionJudith S Hochman, Harmony R Reynolds, Vladimír Dzavík, et al.
American Heart Journal|March 20, 2012
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT)Harmony R Reynolds, Sandra A Forman, Jacqueline E Tamis-Holland, et al.
Circulation|March 29, 2014
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice GuidelinesJeffrey L Anderson, Paul A Heidenreich, Paul G Barnett, et al.
Journal of the American College of Cardiology|April 1, 2014
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice GuidelinesJeffrey L Anderson, Paul A Heidenreich, Paul G Barnett, et al.
JAMA|December 7, 2006
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantationEric L Eisenstein, Kevin J Anstrom, David F Kong, et al.
Circulation. Cardiovascular Quality and Outcomes|December 7, 2020
Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection FractionDerek S Chew, Zak Loring, Jatin Anand, et al.
JAMA Cardiology|November 5, 2022
Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic DissectionE Hope Weissler, Oyomoare L Osazuwa-Peters, Melissa A Greiner, et al.
Circulation. Arrhythmia and Electrophysiology|April 13, 2021
Treatment-Related Changes in Left Atrial Structure in Atrial Fibrillation: Findings From the CABANA Imaging SubstudyMaryam E Rettmann, David R Holmes, Kristi H Monahan, et al.
Pageof 34